Home Welcome to your new journal: Medical Review
Article Open Access

Welcome to your new journal: Medical Review

  • Qimin Zhan EMAIL logo
Published/Copyright: January 11, 2022

The outbreak of coronavirus disease 2019 (COVID-19) in early 2020 has rattled the world with resounding economic, social and political implications [1], [2], [3], [4]. On a somewhat positive side of the story, the pandemic has put health and medicine under the limelight and brought the world to look at it from a higher and broader perspective. This rising prominence, however, creates as much opportunity as it poses challenge. It challenges us to break down both the silo that medicine is and the silos that medicine has, so as to improve health care, reduce health burden, advance health technology, identify and respond to emerging health threats, and meet health needs.

Yet the COVID-19 pandemic is by no means all that we face in health and medicine. Even at the height of this global public health crisis, it cannot overshadow the long-standing hazards brought about by non-communicable diseases, such as cancer as well as cardiovascular, cerebrovascular, neurodegenerative, metabolic and respiratory diseases [5], [6], [7], [8].

Confronting multi-faceted health issues, the world has come to realize that resonance of these issues goes beyond wellbeing to encompass national security, social stability, economic development, and international politics and relations [9], [10], [11], [12]. With this renewed understanding, countries around the world will deploy massive projects, in a bid to meet their strategic needs, respond to new challenges, and discover blue-ocean opportunities at the frontier of medical sciences. These projects will feature disease-orientated approach, advanced biotechnology, interdisciplinarity and disruptive innovation.

In such context, the launch of Medical Review (MR) is most opportune. The journal started as a proposal by Prof. Han Qide, honorary president of China Association for Science and Technology and former executive vice president of Peking University. As editor-in-chief, I’m deeply grateful for his proposal and for the collective efforts over the last two years behind the delivery of that proposal.

We envision the MR as a medical journal devoted to reviews, one that is of strategic importance in informing the field of the latest development. It will review representative studies, track progress, interpret hot topics, and analyze policies. Aiming at leading medical journals in the world, the MR will uphold high standards for individual articles and for the journal itself, through its international editorial board and rigorous peer review.

Your submission and subscription will be most welcome. Either way, it is our hope that you enjoy the journal.


Corresponding author: Qimin Zhan, Peking University Health Science Centre, Xueyuan Road #38, Beijing 100083, China, E-mail:

References

1. Kola, L, Kohrt, BA, Charlotte Hanlon, C, Naslund, JA, Sikander, S, Balaji, M, et al.. COVID-19 mental health impact and responses in low-income and middle-income countries: reimagining global mental health. Lancet Psychiatr 2021;8:535–50. https://doi.org/10.1016/s2215-0366(21)00025-0.Search in Google Scholar

2. Lavine, SJ, Bjornstad, ON, Antia, R. Immunological characteristics govern the transition of COVID-19 to endemicity. Science 2021;371:741–5. https://doi.org/10.1126/science.abe6522.Search in Google Scholar

3. Torjesen, I. Covid-19 will become endemic but with decreased potency over time, scientists believe. BMJ 2021;372:n494. https://doi.org/10.1136/bmj.n494.Search in Google Scholar

4. Global Burden of Disease 2020 Health Financing Collaborator Network. Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990–2050. Lancet 2021;398:1317–43. https://doi.org/10.1016/S0140-6736(21)01258-7.Search in Google Scholar

5. Madan, A, Siglin, J, Khan, A. Comprehensive review of implications of COVID-19 on clinical outcomes of cancer patients and management of solid tumors during the pandemic. Cancer Med 2020;9:9205–18. https://doi.org/10.1002/cam4.3534.Search in Google Scholar

6. Singh, AK, Gupta, R, Ghosh, A, Misra, A. Diabetes in COVID-19: prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab Syndr 2020;14:303–10. https://doi.org/10.1016/j.dsx.2020.04.004.Search in Google Scholar

7. Meyer, NJ, Gattinoni, L, Calfee, CS. Acute respiratory distress syndrome. Lancet 2021;398:622–37. https://doi.org/10.1016/s0140-6736(21)00439-6.Search in Google Scholar

8. Vogel, B, Acevedo, M, Appelman, Y, Bairey Merz, CN, Chieffo, A, Figtree, GA, et al.. The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030. Lancet 2021;397:2385–438. https://doi.org/10.1016/s0140-6736(21)00684-x.Search in Google Scholar

9. Li, X, Krumholz, HM, Yip, W, Cheng, KK, De Maeseneer, J, Meng, Q, et al.. Quality of primary health care in China: challenges and recommendations. Lancet 2020;395:1802–12. https://doi.org/10.1016/s0140-6736(20)30122-7.Search in Google Scholar

10. Perugini, C, Vladisavljević, M. Social stability challenged by Covid-19: pandemics, inequality and policy responses. J Pol Model 2021;43:146–60. https://doi.org/10.1016/j.jpolmod.2020.10.004.Search in Google Scholar PubMed PubMed Central

11. Abrams, EM, Szefler, SJ. COVID-19 and the impact of social determinants of health. Lancet Respir Med 2020;8:659–61. https://doi.org/10.1016/s2213-2600(20)30234-4.Search in Google Scholar

12. Wise, PH, Shiel, A, Southard, N, Bendavid, E, Welsh, J, Stedman, S, et al.. The political and security dimensions of the humanitarian health response to violent conflict. Lancet 2021;397:511–21. https://doi.org/10.1016/s0140-6736(21)00130-6.Search in Google Scholar

Published Online: 2022-01-11
Published in Print: 2021-10-26

© 2021 Qimin Zhan, published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Downloaded on 27.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/mr-2021-0030/html
Scroll to top button